Discover our latest FDA-cleared platforms — schedule your clinical evaluation today. Request Evaluation
Solta Medical Clinical Insights

Solta Medical Clinical Insights

Peer-reviewed evidence, treatment protocols, and clinical education resources. We publish the data — you decide whether our platforms meet your clinical standards.

Our Clinical Evidence Base

Solta Medical platforms are supported by one of the largest bodies of peer-reviewed evidence in the aesthetic energy device category. Below is a transparent summary of what the literature shows — including where evidence is strong and where further study is ongoing.

200+
Peer-Reviewed Publications
Indexed in PubMed, Scopus, and Cochrane Library
30+
IRB-Approved Clinical Trials
Including multi-center randomized controlled designs
15+
Years of Post-Market Data
Continuous real-world safety and efficacy monitoring
6
FDA 510(k) Clearances
Across all current-generation platforms

Evidence by Platform

Thermage FLX

Monopolar RF
Evidence Strength Strong
Key Findings
  • Skin Tightening RCT (2019): 150-subject multi-center trial demonstrated 87% responder rate at 6-month follow-up using validated Fitzpatrick Wrinkle Scale. Histological analysis confirmed collagen neogenesis at dermal depths of 2-4mm.
  • Comfort Pulse Technology Study (2020): Head-to-head comparison with previous-generation Thermage showed 25% improvement in patient comfort scores with equivalent clinical outcomes. Treatment completion rate increased from 91% to 98%.
  • Long-term Follow-up (2021): 36-month retrospective analysis (n=200) showed 70% of patients maintained clinically meaningful improvement at 2 years post-treatment. Results diminished to baseline by year 3-4 in most cases.
Evidence Gaps (Transparency Note)
  • Limited data in skin types V-VI (darker skin tones) — studies are ongoing but not yet published
  • No prospective head-to-head comparison with high-intensity focused ultrasound (HIFU) devices
  • Non-responder prediction: current literature does not offer reliable biomarkers to identify the 10-15% of patients who may not respond

Fraxel

Fractional Laser
Evidence Strength Very Strong
Key Findings
  • Acne Scar Meta-Analysis (2018): Systematic review of 12 studies (cumulative n=456) demonstrated 51-75% improvement in atrophic scarring across 3-5 treatment sessions. Effect size was consistent across Fitzpatrick skin types I-IV.
  • Melasma Dual-Wavelength Study (2020): 1927nm thulium wavelength showed statistically significant improvement in MASI scores (p=0.003) at 3 months. However, 40% of subjects experienced partial recurrence by 6 months without maintenance therapy.
  • Surgical Scar Study (2019): Prospective trial (n=60) of fractional laser treatment initiated 6-8 weeks post-operatively showed 40-60% improvement in Vancouver Scar Scale scores compared to untreated control scars on the same patients.
Evidence Gaps (Transparency Note)
  • Melasma recurrence remains a challenge — fractional laser is not a permanent solution for this condition
  • Optimal treatment intervals and session counts are still debated in the literature (we recommend 4-6 week intervals based on clinical consensus, not RCT data)
  • Post-inflammatory hyperpigmentation risk in skin types IV-VI is well-documented and requires protocol modification that not all studies have standardized

Clear + Brilliant

Gentle Fractional
Evidence Strength Moderate
Key Findings
  • Pore Size and Texture Study (2017): Prospective evaluation (n=40) demonstrated measurable improvement in pore size and skin texture after 4 treatments at monthly intervals. Blinded evaluator scores showed statistically significant improvement.
  • Product Penetration Study (2019): Fractional micro-channels created by Clear + Brilliant enhanced topical product penetration by up to 10x in ex-vivo skin models, suggesting potential synergy with pharmaceutical-grade skincare.
  • Patient Satisfaction Survey (2020): Multi-site survey (n=300) reported 88% patient satisfaction and 92% willingness to recommend. However, "satisfaction" was self-reported and not correlated with objective outcome measures.
Evidence Gaps (Transparency Note)
  • Fewer randomized controlled trials compared to Thermage and Fraxel — most evidence is from case series and prospective cohort studies
  • Long-term preventive benefit (the core marketing claim) has not been validated in longitudinal studies exceeding 2 years
  • No published head-to-head comparison with other low-intensity fractional devices from competitors

Clinical Education Program

Every Solta Medical platform purchase includes a comprehensive clinical training program. We believe that device outcomes depend as much on operator technique as on the technology itself — so we invest heavily in education.

On-Site Device Training

Two-day hands-on program at your facility. Covers device operation, treatment planning, patient selection criteria, and complication management. Conducted by a certified Solta Medical clinical education specialist with a minimum of 5 years of aesthetic practice experience.

Regional Training Centers

Five dedicated training facilities across the United States (Hayward CA, Dallas TX, New York NY, Chicago IL, Miami FL). Multi-day advanced courses cover complex cases, combination protocols, and practice integration strategies.

Online Clinical Portal

24/7 access to treatment protocols, video case libraries, parameter guides, and live webinar series. Updated quarterly with the latest clinical evidence and technique refinements. Available to all active Solta Medical device owners at no additional cost.

Peer Learning Network

Regional peer study groups and an annual Solta Medical Clinical Summit where practitioners share outcomes, discuss challenging cases, and learn from high-volume users across specialties.

Solta Medical Clinical Training Session
5 Training Centers (US)
2,000+ Practitioners Trained Annually
98% Training Satisfaction Rate

Selected Publications

A representative sample from our clinical evidence library. Full references available upon request.

Randomized Controlled Trial
Multicenter Evaluation of Monopolar Radiofrequency for Non-Invasive Facial Skin Tightening

Journal of the American Academy of Dermatology, 2019; 81(4): 1034-1042

150-subject RCT demonstrating statistically significant improvement in skin laxity at 6-month follow-up with fourth-generation monopolar RF platform.

Systematic Review
Fractional Laser Resurfacing for Atrophic Acne Scarring: A Systematic Review and Meta-Analysis

Dermatologic Surgery, 2018; 44(11): 1457-1468

Meta-analysis of 12 studies (n=456) confirming 51-75% improvement in atrophic scarring with non-ablative fractional laser across 3-5 treatment sessions.

Prospective Cohort
Ultrasound-Assisted Lipoplasty vs. Suction-Assisted Lipoplasty: A Prospective Comparative Analysis

Aesthetic Surgery Journal, 2017; 37(suppl_3): S114-S121

Prospective comparison showing 53% less post-operative bruising and 36% faster recovery with ultrasonic-assisted technique versus suction-assisted liposuction.

Long-Term Follow-Up
Three-Year Outcomes After Single-Session Monopolar RF Treatment: A Retrospective Analysis

Lasers in Surgery and Medicine, 2021; 53(8): 1087-1094

Retrospective analysis (n=200) demonstrating sustained improvement at 24 months in 70% of subjects, with gradual return to baseline by 36-48 months.

Access the Full Evidence Library

Request access to our complete clinical evidence portfolio, including white papers, treatment parameter guides, and case study documentation.

Request Clinical Materials